Detalhe da pesquisa
1.
Constitutively Synergistic Multiagent Drug Formulations Targeting MERTK, FLT3, and BCL-2 for Treatment of AML.
Pharm Res
; 40(9): 2133-2146, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37704893
2.
Novel 1,2-dihydroquinazolin-2-ones: Design, synthesis, and biological evaluation against Trypanosoma brucei.
Bioorg Med Chem Lett
; 27(16): 3629-3635, 2017 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28729055
3.
Constitutively synergistic multiagent drug formulations targeting MERTK, FLT3, and BCL-2 for treatment of AML.
bioRxiv
; 2023 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36993676
4.
Development of constitutively synergistic nanoformulations to enhance chemosensitivity in T-cell leukemia.
J Control Release
; 361: 470-482, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37543290
5.
Discovery of Tetrahydropyridopyrimidines as Irreversible Covalent Inhibitors of KRAS-G12C with In Vivo Activity.
ACS Med Chem Lett
; 9(12): 1230-1234, 2018 Dec 13.
Artigo
Inglês
| MEDLINE | ID: mdl-30613331